Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0NM6R
|
||||
| Former ID |
DNC009449
|
||||
| Drug Name |
N-3'-ethylaplysinopsin
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [526321] | ||
| Formula |
C16H18N4O
|
||||
| Canonical SMILES |
CCN=C1N(C(=CC2=CNC3=CC=CC=C32)C(=O)N1C)C
|
||||
| InChI |
1S/C16H18N4O/c1-4-17-16-19(2)14(15(21)20(16)3)9-11-10-18-13-8-6-5-7-12(11)13/h5-10,18H,4H2,1-3H3/b14-9+,17-16?
|
||||
| InChIKey |
WPOIHWRJVKWRCZ-ZWKBEUAESA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [526321] | |
| 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [526321] | ||
| WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
| Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| SIDS Susceptibility Pathways | |||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.